Section 5
Références
Saklayen M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Current hypertension reports, 20(2), 12.
Huang P. L. (2009). A comprehensive definition for metabolic syndrome. Disease models & mechanisms, 2(5-6), 231–237.
Lemieux, I., & Després, J. P. (2020). Metabolic Syndrome: Past, Present and Future. Nutrients, 12(11), 3501
Sherling, D. H., Perumareddi, P., & Hennekens, C. H. (2017). Metabolic Syndrome. Journal of cardiovascular pharmacology and therapeutics, 22(4), 365–367.
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021). Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes & metabolism journal, 45(3), 285–311.
Love, K. M., & Liu, Z. (2021). DPP4 Activity, Hyperinsulinemia, and Atherosclerosis. The Journal of clinical endocrinology and metabolism, 106(6), 1553–1565.
Hegde, V., Dhurandhar, N. V., & Reddy, P. H. (2019). Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?. Journal of Alzheimer’s disease : JAD, 72(s1), S71–S79.
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009). Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet (London, England), 373(9682), 2215–2221.